美国食品药品管理局（FDA）和疾控中心（CDC）建议，60岁以上人群暂停接种基孔肯雅热疫苗。

Core Viewpoint - The FDA and CDC have recommended that individuals aged 60 and above pause the administration of the chikungunya vaccine [1] Group 1 - The recommendation affects a specific demographic, indicating potential implications for public health and vaccine distribution strategies [1]